[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Last site contents
:: Editorial Board
:: About Iranian Journal of Endocrinology and Metabolism
:: Volume 24, Issue 5 (12-2022) ::
2022, 24(5): 292-300 Back to browse issues page
Estimation of the Direct Cost of Diabetes in Ahvaz (the Southwest of Iran): A Descriptive-Analytical Study
L Yazdanpanah , H Shahbazian , S Ghanbari , L Moradi , A Moravej Aleali , S.M Bahreinian , Sh Molavi Nejad , M Adineh
Health Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, , Yazdanpanah.l@ajums.ac.ir
Abstract:   (458 Views)
Introduction: Diabetes and its complications have a significant economic effect on society. This study evaluated the annual cost of patients with diabetes in Ahvaz, Iran, for the first time to reduce diabetes costs by identification of cost-induced factors. Materials and Methods: A questionnaire was completed for each of 752 patients referring to diabetes clinics in a university hospital. Then, the patients recorded all diabetes-related costs through face-to-face or telephone interviews for one year, including transportation, physician visit, drugs, laboratory tests and imaging, diet prescription, hospitalization, glucometer strips, etc. The patients reported their costs every three months. Results: The per capita cost of patients with diabetes was USD 1611.19 ± 1366.67 annually. Women had higher per capita costs than men did. The cost of taking medication was the highest compared to other costs (while the cost of diet prescription was the lowest. Of all patients, 14.2 % had at least one diabetic complication. Diabetes-related cardiovascular complications had the highest annual cost for patients. There is no statistically significant correlation between diabetes cost and gender or diabetes duration. Conclusions:  The cost of medications constitutes a major portion of the total direct cost of this disease, whereas the cost of diet prescription was the lowest. Diabetes and its complications have a significant economic effect on the health system. Control of diabetes and complication prevention should be considered to reduce the costs it imposes on the society.
Keywords: Direct per capita cost, Diabetes, Complications of diabetes, Cost of illness
Full-Text [PDF 875 kb]   (301 Downloads)    
Type of Study: Original | Subject: Endocrinology
Received: 2023/03/7 | Accepted: 2023/06/7 | Published: 2022/12/31
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Yazdanpanah L, Shahbazian H, Ghanbari S, Moradi L, Moravej Aleali A, Bahreinian S, et al . Estimation of the Direct Cost of Diabetes in Ahvaz (the Southwest of Iran): A Descriptive-Analytical Study. Iranian Journal of Endocrinology and Metabolism 2022; 24 (5) :292-300
URL: http://ijem.sbmu.ac.ir/article-1-3071-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 5 (12-2022) Back to browse issues page
مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه  پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، Iranian Journal of Endocrinology and Metabolism
Persian site map - English site map - Created in 0.06 seconds with 38 queries by YEKTAWEB 4642